Kappa Bioscience announces newest member of its scientific and medical advisory board

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board, which was formed under the guidance of Bernie Landes MBA, president of Nutritional Products Consulting Group LLP, who is now executive director of the board. According to Kappa, the appointment solidifies its strategic commitment to support and expand the scientific knowledge base of vitamin K2.

In addition to supporting the board, Repine will continue his duties s the Waring Endowed Professor of Medicine, Pediatrics, and Surgery, the Webb-Waring Center Director, and the Associate Dean for Student Advocacy at the University of Colorado School of Medicine in Aurora, Colorado. He brings a wealth of scientific research and expertise to the board, specializing in inflammation, oxidative stress, neutrophils, macrophages, electromagnetic fields, and Acute Respiratory Distress Syndrome (ARDS).

“I'm honored to have been invited to join this esteemed group of top-class experts,” said Repine. “I look forward to supporting the Kappa Bioscience team to expand awareness of vitamin K2 and uncover the full scope of health benefits it can offer."

“We’re excited to welcome Dr. Repine as the newest member of our Advisory Board,” said Egil Greve, Kappa Bioscience president and CEO, in a press release. “With his extensive scientific expertise, combined with our highly qualified internal science team, we aim to expand the scope of scientific research into K2 and raise further awareness about its role in maintaining health.”

Repine joins a lineup of world authorities in multiple relevant scientific fields, including cardiology, immunology, kinesiology, and molecular nutrition, which was formed to set a new standard for the scientific support and advancement of emerging nutritional compounds. Other founding members of the Board include: Dr. John Ivy, the Teresa Lozano Long Endowed Chair Emeritus at the University of Texas at Austin; Dr. Susanne Talcott, Associate Professor Texas A&M University, Food Science & Technology, Molecular Researcher; and Dr. Nathan Wong, cardiovascular epidemiologist, a specialist in preventive cardiology, and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California.